Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does trastuzumab emtansine's patent expiry affect drug prices?Mobic injection patent oehringer ingelheim france?Patent term adjustment semaglutida?When will latisse patent expire?What's the impact of mixing lipitor bp meds negatively?
See the DrugPatentWatch profile for lipitor
Lipitor (atorvastatin), a statin that lowers cholesterol by inhibiting HMG-CoA reductase in the liver, has no direct pharmacokinetic interaction with NSAIDs like ibuprofen or naproxen. They do not significantly alter each other's metabolism via CYP3A4 or other pathways—atorvastatin is primarily CYP3A4-metabolized, while most NSAIDs rely on CYP2C9 or glucuronidation.[1][2]
The key concern is additive effects on kidneys. Both drugs can reduce renal blood flow: statins mildly via endothelial effects, NSAIDs potently by inhibiting prostaglandins that maintain glomerular filtration. Co-use raises acute kidney injury (AKI) risk, especially in dehydrated patients, those over 65, or with preexisting CKD.[3][4] - In a cohort of 12,000+ statin users, NSAID initiation doubled AKI odds (OR 1.8) within 30 days.[5] - Risk peaks early (first 15-30 days) and resolves after NSAID discontinuation.[3]
Switch to acetaminophen for pain (no renal prostaglandin effect). For inflammation, consider low-dose NSAIDs with hydration and renal function checks, or non-drug options like PT.[9] [1] FDA Lipitor Label [2] Drugs.com Interaction Checker: Atorvastatin + Ibuprofen [3] BMJ 2013: Statins and AKI Risk with NSAIDs [4] JAMA Intern Med 2017: Combined Renal Risks [5] Kidney Int 2016: Cohort Analysis [6] Lexicomp: Atorvastatin Monograph [7] FDA Label Section 5.2 [8] ACC Expert Consensus on Statin Safety [9] UpToDate: NSAID Alternatives in CKD
Other Questions About Lipitor :